These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 30379896

  • 1. Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy.
    Haddix SG, Lee YI, Kornegay JN, Thompson WJ.
    PLoS One; 2018; 13(10):e0205926. PubMed ID: 30379896
    [Abstract] [Full Text] [Related]

  • 2. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.
    Pratt SJP, Shah SB, Ward CW, Inacio MP, Stains JP, Lovering RM.
    J Physiol; 2013 Jan 15; 591(2):559-70. PubMed ID: 23109110
    [Abstract] [Full Text] [Related]

  • 3. Dystrophin is required for organizing large acetylcholine receptor aggregates.
    Kong J, Anderson JE.
    Brain Res; 1999 Aug 28; 839(2):298-304. PubMed ID: 10519053
    [Abstract] [Full Text] [Related]

  • 4. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM, van Putten M, Niks EH, Verschuuren JJ, Aartsma-Rus A, Plomp JJ.
    Eur J Neurosci; 2016 Jun 28; 43(12):1623-35. PubMed ID: 27037492
    [Abstract] [Full Text] [Related]

  • 5. Acetylcholine receptor organization at the dystrophic extraocular muscle neuromuscular junction.
    Marques MJ, Pertille A, Carvalho CL, Santo Neto H.
    Anat Rec (Hoboken); 2007 Jul 28; 290(7):846-54. PubMed ID: 17492672
    [Abstract] [Full Text] [Related]

  • 6. Expression of utrophin at dystrophin-deficient neuromuscular synapses of mdx mice: a study of protected and affected muscles.
    Ferretti R, Neto HS, Marques MJ.
    Anat Rec (Hoboken); 2011 Feb 28; 294(2):283-6. PubMed ID: 21235003
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations of neuromuscular junctions in Duchenne muscular dystrophy.
    Lovering RM, Iyer SR, Edwards B, Davies KE.
    Neurosci Lett; 2020 Oct 15; 737():135304. PubMed ID: 32818587
    [Abstract] [Full Text] [Related]

  • 10. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ.
    J Cell Biol; 2001 Mar 19; 152(6):1207-18. PubMed ID: 11257121
    [Abstract] [Full Text] [Related]

  • 11. Low dystrophin levels are insufficient to normalize the neuromuscular synaptic abnormalities of mdx mice.
    van der Pijl EM, van Putten M, Niks EH, Verschuuren JJGM, Aartsma-Rus A, Plomp JJ.
    Neuromuscul Disord; 2018 May 19; 28(5):427-442. PubMed ID: 29631954
    [Abstract] [Full Text] [Related]

  • 12. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury.
    Pratt SJP, Shah SB, Ward CW, Kerr JP, Stains JP, Lovering RM.
    Cell Mol Life Sci; 2015 Jan 19; 72(1):153-64. PubMed ID: 24947322
    [Abstract] [Full Text] [Related]

  • 13. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
    Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR.
    Cell; 1997 Aug 22; 90(4):729-38. PubMed ID: 9288752
    [Abstract] [Full Text] [Related]

  • 14. Participation of myosin Va and Pka type I in the regeneration of neuromuscular junctions.
    Röder IV, Strack S, Reischl M, Dahley O, Khan MM, Kassel O, Zaccolo M, Rudolf R.
    PLoS One; 2012 Aug 22; 7(7):e40860. PubMed ID: 22815846
    [Abstract] [Full Text] [Related]

  • 15. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.
    Tjondrokoesoemo A, Schips TG, Sargent MA, Vanhoutte D, Kanisicak O, Prasad V, Lin SC, Maillet M, Molkentin JD.
    J Biol Chem; 2016 May 06; 291(19):9920-8. PubMed ID: 26966179
    [Abstract] [Full Text] [Related]

  • 16. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M, Ehara Y, Li J, Inada K, Ohno K.
    Hum Gene Ther; 2017 May 06; 28(5):428-436. PubMed ID: 27485975
    [Abstract] [Full Text] [Related]

  • 17. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
    Hui T, Jing H, Zhou T, Chen P, Liu Z, Dong X, Yan M, Ren D, Zou S, Wang S, Fei E, Hong D, Lai X.
    Hum Mol Genet; 2021 Aug 12; 30(17):1579-1590. PubMed ID: 33987657
    [Abstract] [Full Text] [Related]

  • 18. Axonal sprouting in mdx mice and its relevance to cell and gene mediated therapies for Duchenne muscular dystrophy.
    Santo Neto H, Martins AJ, Minatel E, Marques MJ.
    Neurosci Lett; 2003 May 29; 343(1):67-9. PubMed ID: 12749999
    [Abstract] [Full Text] [Related]

  • 19. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.
    Leite PE, Gandía L, de Pascual R, Nanclares C, Colmena I, Santos WC, Lagrota-Candido J, Quirico-Santos T.
    Brain Res; 2014 Jul 21; 1573():27-36. PubMed ID: 24833065
    [Abstract] [Full Text] [Related]

  • 20. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Marques MJ, Ferretti R, Vomero VU, Minatel E, Neto HS.
    Muscle Nerve; 2007 Mar 21; 35(3):349-53. PubMed ID: 17143878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.